Marguerite Littleton Kearney
Marguerite Littleton Kearney is a distinguished nurse and researcher known for her significant contributions to the field of nursing science. She is currently the Director of the National Institute of Nursing Research (NINR) at the National Institutes of Health (NIH).
Early Life and Education[edit | edit source]
Marguerite Littleton Kearney was born and raised in America. She pursued her Bachelor's degree in Nursing from the University of Alabama, followed by a Master's degree in Nursing from the University of South Alabama. Kearney later earned her Ph.D. in Nursing from the University of California, San Francisco.
Career[edit | edit source]
Kearney began her career as a nurse practitioner specializing in cardiovascular disease. She then transitioned into research, focusing on the prevention of cardiovascular disease in women. Kearney's research has been instrumental in understanding the role of behavioral science in preventing cardiovascular disease.
In 2015, Kearney joined the National Institute of Nursing Research (NINR) as a program director in the Division of Extramural Science Programs (DESP). She was later appointed as the Director of NINR in 2020.
Contributions to Nursing Research[edit | edit source]
Kearney's research has significantly contributed to the understanding of cardiovascular disease prevention in women. Her work has highlighted the importance of lifestyle modifications, such as diet and exercise, in preventing cardiovascular disease.
Kearney has also been instrumental in promoting nursing science at the national level. As the Director of NINR, she has advocated for the integration of nursing science into the broader biomedical research community.
Awards and Recognition[edit | edit source]
Kearney has received numerous awards and recognition for her contributions to nursing and research. These include the American Heart Association's Award for Meritorious Achievement and the National Institutes of Health's Award for Superior Service.
References[edit | edit source]
 | This medical article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
